RIPK1 and cancer: Shikonin is the main active ingredient in the Chinese medicine "Zicao", which regulates PI3K/AKT/mTOR and MAPK signaling and exerts a strong anticancer effect on various types of cancer by inhibiting RIPK1/3, which ultimately inhibits cell proliferation and induces necroptosis.